Dioscorea bulbifera L. delays the excretion of doxorubicin and aggravates doxorubicin-induced cardiotoxicity and nephrotoxicity by inhibiting the expression of P-glycoprotein in mice liver and kidney

References

• Abou EI Hassan MA, Kedde MA, Zwiers UT. (2003). The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice. Cancer Chemother Pharmacol 51:306–10.
   PubMed Web of Science ®Google Scholar
• Cappetta D, Rossi F, Piegari E, et al. (2018). Doxorubicin targets multiple players: a new view of an old problem. Pharmacol Res 127:4–14.
   PubMed Web of Science ®Google Scholar
• Chen N, Cui D, Wang Q, et al. (2018). In vitro drug–drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes. Xenobiotica 48:637–46.
   PubMed Web of Science ®Google Scholar
• Choi YH, Lee YK, Lee MG. (2013). Effects of 17 α-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin. Xenobiotica 43:901–7.
   PubMed Web of Science ®Google Scholar
• Durmus S, Naik J, Buil L, et al. (2014). In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters. Int J Cancer 135:1700–10.
   PubMed Web of Science ®Google Scholar
• El-sherbiny NM, El-Sherbiny M. (2014). Thymoquinone attenuates doxorubicininduced nephrotoxicity in rats: role of Nrf2 and NOX4. Chem Biol Interact 223:102–8.
   PubMed Web of Science ®Google Scholar
• Kim TH, Shin S, Yoo SD. (2018). Effects of phytochemical P-Glycoprotein modulators on the pharmacokinetics and tissue distribution of doxorubicin in mice. Molecules 23:E349.
   PubMed Web of Science ®Google Scholar
• Komori Y, Arisawa S, Takai M, et al. (2014). Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells. Eur J Pharmacol 724:161–7.
   PubMed Web of Science ®Google Scholar
• Li R, Barton HA, Varma MV. (2014). Prediction of pharmacokinetics and drug–drug interactions when hepatic transporters are involved. Clin Pharmacokinet 53:659–78.
   PubMed Web of Science ®Google Scholar
• Lund M, Petersen TS, Dalhoff KP, et al. (2017). Clinical implications of P-glycoprotein modulation in Drug-Drug Interactions. Drugs 77:859–883.
   PubMed Web of Science ®Google Scholar
• Meng Q, Liu K. (2014). Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab 15:791–807.
   PubMed Web of Science ®Google Scholar
• Mohajeri M, Sahebkar A. (2018). Protective effects of curcumin against doxorubicininduced toxicity and resistance: A review. Crit Rev Oncol Hematol 122:30–51.
   PubMed Web of Science ®Google Scholar
• Niu C, Wang J, Ji L, et al. (2014). Protection of Angelica sinensis (Oliv) Diels against hepatotoxicity induced by Dioscorea bulbifera L. and its mechanism. Biosci Trends 8:253–9.
   PubMed Web of Science ®Google Scholar
• Patel KJ, Tannock IF. (2009). The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors. BMC Cancer 9:356
   PubMed Web of Science ®Google Scholar
• Pfizer Inc. (2013). Prescribing information for doxorubicin hydrochloride. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/ 050467s073lbl.pdf [last accessed 19 Jul 2018].
   Google Scholar
• Pugazhendhi A, Edison TNJI, Velmurugan BK, et al. (2018). Toxicity of Doxorubicin (Dox) to different experimental organ systems. Life Sci 200:26–30.
   PubMed Web of Science ®Google Scholar
• Qu XY, Tao LN, Zhang SX, et al. (2017). The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice. Environ Toxicol Pharmacol 51:16–22.
   PubMed Web of Science ®Google Scholar
• Romagnoli KM, Nelson SD, Hines L, et al. (2017). Information needs for making clinical recommendations about potential drug–drug interactions: a synthesis of literature review and interviews. BMC Med Inform Decis Mak 17:21
   PubMed Web of Science ®Google Scholar
• Sheng Y, Ma Y, Deng Z, et al. (2014). Cytokines as potential biomarkers of liver toxicity induced by Dioscorea bulbifera L. Biosci Trends 8:32–7.
   PubMed Web of Science ®Google Scholar
• Szwed M, Kania KD, Jozwiak Z. (2014). Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin. Cell Oncol (Dordr) 37:421–8.
   PubMed Web of Science ®Google Scholar
• Tachibana T, Kato M, Takano J, et al. (2010). Predicting drug–drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein . Curr Drug Metab 11:762–77.
   PubMed Web of Science ®Google Scholar
• Wei W, Wu XM, Li YJ. 2010. Experimental Methodology of Pharmacology. 4th ed. Beijing, PR China: People’s Medical Publishing House.
   Google Scholar
• Yang F, Liang Y, Xu L, et al. (2016). Exploration in the cascade working mechanisms of liver injury induced by total saponins extracted from Rhizoma Dioscorea Bulbifera. Biomed Pharmacother 83:1048–56.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu Y, Qi Y, et al. (2017). Protective effects of dioscin against doxorubicininduced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation. Toxicology 378:53–64.
   PubMed Web of Science ®Google Scholar
• Zhao L, Tao X, Qi Y, et al. (2018). Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Redox Biol 16:189–98.
   PubMed Web of Science ®Google Scholar
• Zhao L, Qi Y, Xu L, et al. (2018). MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol 15:284–96.
   PubMed Web of Science ®Google Scholar
• Zheng WY, Richardson LC, Li L, et al. (2018). Drug–-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol 74:15–27.
   PubMed Web of Science ®Google Scholar